In the last trading session, 4,585,462 shares of the BioHiTech Global, Inc. (NASDAQ:BHTG) were traded, and its beta was 1.29. Most recently the company’s share price was $1.77, and it changed around $0.14 or 0.09% from the last close, which brings the market valuation of the company to $41.34 Million. BHTG currently trades at a discount to its 52-week high of $4.4, offering almost -148.59% off that amount. The share price’s 52-week low was $1.05, which indicates that the current value has risen by an impressive 40.68% since then. We note from BioHiTech Global, Inc.’s average daily trading volume that its 10-day average is 413.62 Million shares, with the 3-month average coming to 2.39 Million.
BioHiTech Global, Inc. stock received a consensus recommendation rating of Buy, based on a mean score of 2. If we narrow it down even further, the data shows that none out of 1 analysts rate the stock as a Sell; another but none rate it as Overweight. Among the rest, no body recommended BHTG as a Hold, whereas 1 deemed it a Buy, and no one rated it as Underweight. BioHiTech Global, Inc. is expected to report earnings per share of -$0.08 for the current quarter.
BioHiTech Global, Inc. (NASDAQ:BHTG): Trading Information
Instantly BHTG has showed a green trend with a performance of 8.59% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of $1.83 on Tuesday, Apr 06 increased the stock’s daily price by 3.28%. The company’s shares are currently up 0.58% year-to-date, but still up 0.1569 over the last five days. On the other hand, BioHiTech Global, Inc. (NASDAQ:BHTG) is 0.13% up in the 30-day period. We can see from the shorts that 176.19 Million shares have been sold at a short interest cover period of 73.72 day (s).
The consensus price target as assigned by Wall Street analysts is $5, which translates to bears needing to increase their stock price by 182.49% from its current value. Analyst projections state that BHTG is forecast to be at a low of $5 and a high of $5. In order for the stock price to hit the forecast high, the stock would need to surge +182.49% from its current level, while the stock would need to crash 182.49% from its current level to reach the projected low.
BioHiTech Global, Inc. (BHTG) projections and forecasts
BioHiTech Global, Inc. share prices are not performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen +38.28 percent over the past six months. Moreover, analysts have decided to roll up on their fiscal year 2021 revenue estimates. The rating firms predict that it will gain +46.7% in revenue this quarter, and will report an increase of 56.2% in the next quarter. The year-over-year growth rate is expected to be 11.4%, up from the previous year.
Consensus estimates provided by 1 financial analysts predict the company will bring in an average of $1.32 Million in revenue for the current quarter. 1 analysts expect BioHiTech Global, Inc. to make $1.51 Million in revenue for the quarter ending in May 2021. The company’s sales for the same quarters a year ago were $1.01 Million and $1.18 Million respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 31.2%. Forecasts for the next quarter put sales growth at 28%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of 0%. BioHiTech Global, Inc. earnings are expected to increase by 49.9% in 2021, but the outlook is negative 0% per year for the next five years.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
BioHiTech Global, Inc. (NASDAQ:BHTG)’s Biggest Investors
Upon looking at major shareholders, it appears that insiders hold 22.22% of BioHiTech Global, Inc. shares, and 2.5% of them are in the hands of institutional investors. The stock currently has a share float of 3.22%. BioHiTech Global, Inc. stock is held by 22 institutions, with Raymond James Financial Services Advisors, Inc. being the largest institutional investor. By Dec 30, 2020, it held 0.6% of the shares, which is about 118.69 Thousand shares worth $132.93 Thousand.
Vanguard Group, Inc. (The), with 0.44% or 87.66 Thousand shares worth $98.18 Thousand as of Dec 30, 2020, holds the second largest percentage of outstanding shares.
Fidelity Extended Market Index Fund and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Feb 27, 2021. The former held 91923 shares worth $174.65 Thousand, making up 0.46% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 58.89 Thousand shares worth around $65.96 Thousand, which represents about 0.3% of the total shares outstanding.